Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort'.

ABSTRACT:

SUBMITTER: Veenstra J 

PROVIDER: S-EPMC8440471 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature